Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2–4 years: A phase II randomized study

Pneumococcal conjugate vaccines (PCVs) have been successful in preventing invasive pneumococcal disease but effectiveness has been challenged by replacement of vaccine serotypes with non-vaccine serotypes. Vaccines targeting common pneumococcal protein(s) found in most/all pneumococci may overcome t...

Descripción completa

Detalles Bibliográficos
Autores principales: Odutola, A, Ota, MO, Ogundare, EO, Antonio, M, Owiafe, P, Worwui, A, Greenwood, B, Alderson, M, Traskine, M, Verlant, V, Dobbelaere, K, Borys, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049746/
https://www.ncbi.nlm.nih.gov/pubmed/26618243
http://dx.doi.org/10.1080/21645515.2015.1111496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049746/
https://www.ncbi.nlm.nih.gov/pubmed/26618243
http://dx.doi.org/10.1080/21645515.2015.1111496

Ejemplares similares